Regulation of initial vinblastine influx by P-glycoprotein
Open Access
- 1 January 1993
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 67 (1) , 30-36
- https://doi.org/10.1038/bjc.1993.6
Abstract
P-glycoprotein (PGP) is an energy-dependent efflux pump that serves to protect cells against the cytotoxicity of many natural product drugs including vinblastine (VBL). In this study we investigated the role of PGP in regulating initial VBL influx. The apparent influx of VBL, measured over the first 20 s, was 2-fold lower in KB-GRC1 cells expressing a transfected mdr1 gene at high level than in non-expressing parental KB-3-1 cells. Inhibition of PGP efflux function with dipyridamole increased the influx rate constant by 4.0-fold in the KB-GRC1 cells but only 2.1-fold in the KB-3-1 cells. Verapamil, another inhibitor of PGP-mediated efflux, increased the initial influx rate constant by 2.7-fold in the KB-GRC1 cells but only 1.4-fold in the KB-3-1 cells. Inhibition of PGP function by depletion of ATP increased influx by 6.8-fold and 2.2-fold in the two cell types, respectively. Mutation of PGP at both ATP binding sites abolished its ability to limit initial influx. Thus, VBL is serving as an efficient substrate for the efflux pump even within the first few seconds of drug exposure, consistent with the hypothesis that PGP may directly efflux drug from the cell membrane.Keywords
This publication has 36 references indexed in Scilit:
- Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cellsCell, 1991
- Fast kinetic analysis of drug transport in multidrug resistant cells using a pulsed quench-flow apparatusBiochemical and Biophysical Research Communications, 1990
- Permeabilized cells as a way of gaining access to intracellular organelles: an approach to glycosylation reactionsBiochimie, 1990
- Doxorubicin resistance in P388 leukemia—evidence for reduced drug influxInternational Journal of Cancer, 1989
- Multidrug Resistance: P-glycoprotein and Its Allies--The Elusive FoesJNCI Journal of the National Cancer Institute, 1989
- Potentiation of Some Anticancer Agents by Dipyridamole against Drug-sensitive and Drug-resistant Cancer Cell LinesJapanese Journal of Cancer Research, 1989
- An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) geneCell, 1988
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteinsCell, 1986
- Genetic and biochemical characterization of multidrug resistancePharmacology & Therapeutics, 1985